Lu et al.
2022
Comparison of COVID-19 induced respiratory failure and typical ARDS: similarities and differences
Cavalli et al.
2017
Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure
JP2023166388A5
(cg-RX-API-DMAC7.html )
2024-05-14
JP2004533405A5
(cg-RX-API-DMAC7.html )
2008-11-13
JP2020073536A5
(cg-RX-API-DMAC7.html )
2020-12-03
JP2024010006A5
(cg-RX-API-DMAC7.html )
2024-02-27
Chen et al.
2007
In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions
JPWO2022186282A5
(cg-RX-API-DMAC7.html )
2024-02-08
JP2023134593A
(ja )
2023-09-27
ライノウイルス感染症の予防又は治療のための薬物
JP2018502579A5
(cg-RX-API-DMAC7.html )
2019-02-14
JP2021533801A5
(cg-RX-API-DMAC7.html )
2022-08-31
Kazama et al.
2022
Biopsy-proven fulminant myocarditis requiring mechanical circulatory support following COVID-19 mRNA vaccination
JP2021530249A5
(cg-RX-API-DMAC7.html )
2022-07-19
JP2020510648A5
(cg-RX-API-DMAC7.html )
2021-03-25
JP2023126658A5
(cg-RX-API-DMAC7.html )
2023-10-24
Brzoska et al.
2023
Interferons in COVID-19: missed opportunities to prove efficacy in clinical phase III trials?
JP2021500880A5
(cg-RX-API-DMAC7.html )
2021-11-25
Wollborn et al.
2019
Extracorporeal resuscitation with carbon monoxide improves renal function by targeting inflammatory pathways in cardiac arrest in pigs
Chou et al.
2010
In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles
Zhu et al.
2024
A Case Report of Mycoplasma pneumoniae-induced fulminant myocarditis in a 15-year-old male leading to cardiogenic shock and electrical storm
Wedemeyer et al.
2013
96 weeks of pegylated-Interferon-alpha-2a plus tenofovir or placebo for the treatment of hepatitis delta: the HIDIT-2 study: 31
WO2022056897A1
(zh )
2022-03-24
白细胞介素37与干扰素联用在治疗病毒感染中的应用
JP2024529170A5
(cg-RX-API-DMAC7.html )
2025-08-18
EP4179069A1
(en )
2023-05-17
Methods for treating acute respiratory inflammatory conditions and cytokine storm syndrome
Liu et al.
2011
Republished review: Gene therapy for ocular diseases